• Wed, March 1, 2023

by: WOPRAI

Ashwin Shirvaikar Maintained (TWKS) at Hold with Decreased Target to $8 on, Mar 1st, 2023

by: WOPRAI

Kevin Mcveigh Maintained (TWKS) at Hold with Decreased Target to $10 on, Mar 1st, 2023

by: WOPRAI

Daniel Ford Maintained (TWKS) at Buy with Decreased Target to $12 on, Mar 1st, 2023

by: WOPRAI

Bryan Bergin Maintained (TWKS) at Buy with Decreased Target to $10 on, Mar 1st, 2023

by: WOPRAI

Vamil Divan Initiated (TVTX) at Strong Buy and Held Target at $37 on, Mar 1st, 2023

by: WOPRAI

Salveen Richter Maintained (SRPT) at Strong Buy with Increased Target to $190 on, Mar 1st, 2023

by: WOPRAI

Judah Frommer Maintained (SRPT) at Hold with Increased Target to $144 on, Mar 1st, 2023

by: WOPRAI

Hartaj Singh Maintained (SRPT) at Buy with Increased Target to $180 on, Mar 1st, 2023

by: WOPRAI

Brian Skorney Maintained (SRPT) at Buy with Increased Target to $202 on, Mar 1st, 2023

by: WOPRAI

Brian Abrahams Maintained (SRPT) at Buy with Increased Target to $226 on, Mar 1st, 2023

by: WOPRAI

Gavin Clark-Gartner Maintained (SRPT) at Buy with Increased Target to $171 on, Mar 1st, 2023

by: WOPRAI

Ed Arce Reiterated (CDTX) at Strong Buy and Held Target at $130 on, Mar 1st, 2023

by: WOPRAI

Bernie McTernan Maintained (COMP) at Strong Buy with Decreased Target to $4.5 on, Mar 1st, 2023

by: WOPRAI

Lucas Pipes Downgraded (CENX) to Hold and Held Target at $12 on, Mar 1st, 2023

by: WOPRAI

Menno Hulshof Upgraded (BTE) to Strong Buy on, Mar 1st, 2023

by: WOPRAI

Jason Celino Maintained (BSY) at Buy with Increased Target to $47 on, Mar 1st, 2023

by: WOPRAI

Blair Abernethy Maintained (BSY) at Strong Buy with Increased Target to $43 on, Mar 1st, 2023

by: WOPRAI

Kristen Owen Maintained (BSY) at Buy with Increased Target to $50 on, Mar 1st, 2023

by: WOPRAI

Matthew Hedberg Maintained (BSY) at Buy with Increased Target to $47 on, Mar 1st, 2023

by: WOPRAI

Jason Stewart Downgraded (BRSP) to Hold on, Mar 1st, 2023

by: WOPRAI

Ian Zaffino Maintained (BOWL) at Buy with Increased Target to $19 on, Mar 1st, 2023

by: WOPRAI

John Vinh Maintained (AMBA) at Buy with Increased Target to $105 on, Mar 1st, 2023

by: WOPRAI

Quinn Bolton Reiterated (AMBA) at Strong Buy and Held Target at $100 on, Mar 1st, 2023

by: WOPRAI

Kevin Cassidy Reiterated (AMBA) at Strong Buy and Held Target at $100 on, Mar 1st, 2023

by: WOPRAI

Joseph Moore Maintained (AMBA) at Buy with Decreased Target to $97 on, Mar 1st, 2023

by: WOPRAI

Gary Mobley Maintained (AMBA) at Buy with Increased Target to $100 on, Mar 1st, 2023

by: WOPRAI

Suji Desilva Downgraded (AMBA) to Hold and Held Target at $95 on, Mar 1st, 2023

by: WOPRAI

Christopher Rolland Maintained (AMBA) at Buy with Increased Target to $100 on, Mar 1st, 2023

by: WOPRAI

Tristan Gerra Maintained (AMBA) at Buy with Increased Target to $120 on, Mar 1st, 2023

by: WOPRAI

Richard Shannon Maintained (AMBA) at Strong Buy with Decreased Target to $110 on, Mar 1st, 2023

by: WOPRAI

Quinn Bolton Reiterated (AMAT) at Strong Buy and Held Target at $135 on, Mar 1st, 2023

by: WOPRAI

Mehdi Hosseini Maintained (AMAT) at Hold and Held Target at $125 on, Mar 1st, 2023

by: WOPRAI

Angel Castillo Maintained (AMBP) at Hold with Decreased Target to $5.5 on, Mar 1st, 2023

by: WOPRAI

Alex Henderson Maintained (ALLT) at Strong Buy with Decreased Target to $4.5 on, Mar 1st, 2023

by: WOPRAI

Nehal Chokshi Maintained (ALLT) at Buy with Decreased Target to $11 on, Mar 1st, 2023

by: WOPRAI

Salveen Richter Maintained (ALLO) at Strong Buy with Decreased Target to $31 on, Mar 1st, 2023

by: WOPRAI

Mark Breidenbach Maintained (ALLO) at Buy with Decreased Target to $28 on, Mar 1st, 2023

by: WOPRAI

Luca Issi Maintained (ALLO) at Buy with Decreased Target to $22 on, Mar 1st, 2023

by: WOPRAI

Tony Butler Reiterated (ALLO) at Strong Buy and Held Target at $15 on, Mar 1st, 2023

by: WOPRAI

Andrew Fein Reiterated (ALEC) at Strong Buy and Held Target at $41 on, Mar 1st, 2023

by: WOPRAI

Neena Bitritto-Garg Maintained (ALEC) at Strong Buy with Decreased Target to $12 on, Mar 1st, 2023

by: WOPRAI

Matthew Caufield Reiterated (ALDX) at Strong Buy and Held Target at $15 on, Mar 1st, 2023

by: WOPRAI

Jeff Johnson Maintained (ALC) at Hold with Decreased Target to $75 on, Mar 1st, 2023

by: WOPRAI

Eric Coldwell Maintained (AHCO) at Buy with Decreased Target to $23 on, Mar 1st, 2023

by: WOPRAI

Hans Mosesmann Reiterated (AIP) at Strong Buy and Held Target at $21 on, Mar 1st, 2023

by: WOPRAI

Gus Richard Maintained (AIP) at Buy with Decreased Target to $16 on, Mar 1st, 2023

by: WOPRAI

Fahad Najam Maintained (AKAM) at Hold with Decreased Target to $79 on, Mar 1st, 2023

by: WOPRAI

Robert Dodd Maintained (TCPC) at Buy with Decreased Target to $13 on, Mar 1st, 2023

Serge Belanger Reiterated (ARQT) at Strong Buy and Held Target at $46 on, Mar 1st, 2023

Serge Belanger of Needham, Reiterated "Arcutis Biotherapeutics, Inc." (ARQT) at Strong Buy and Held Target at $46 on, Mar 1st, 2023.

Serge, nor any peers, have made any analyst calls on ARQT in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Like: 👍